期刊文献+

福建省胃癌中低发地区居民血清胃蛋白酶原亚群、胃泌素-17和幽门螺杆菌感染水平分布特征及影响因素 被引量:8

Distributing Characteristics and Their Influencing Factors of Serum Pepsinogens,Gastrin-17,Helicobacter Pylori Infection in Residents in Medium-Low Incidence with Gastric Cancer in Fujian
原文传递
导出
摘要 [目的]了解福建省胃癌中低发地区居民血清PGⅠ、PGⅡ、G-17和Hp感染水平分布特征,探讨用上述血清学标志物筛查高危人群的可能性。[方法]在同安区和福安市随机抽取调查对象进行问卷调查,检测血清PGⅠ、PGⅡ、G-17和Hp感染水平。[结果]PGⅠ水平呈明显的性别、年龄、地区分布差异,PGⅡ、PGⅠ/PGⅡ水平呈明显的地区分布差异。不同Hp感染状态下PGⅠ、PGⅡ、PGⅠ/PGⅡ、G-17水平呈明显差异(P均<0.05)。Logistic回归分析未发现影响PGⅠ、PGⅠ/PGⅡ水平异常的因素,但G-17水平异常的危险因素为Hp感染(OR=2.656)和中年年龄(OR=2.114)。[结论]PGⅠ、PGⅡ、G-17筛查胃癌高危人群具有较广阔的前景。 [Purpose ] To investigate the distributing characteristics of serum PG Ⅰ , PG Ⅱ , G-17 and Hp infection in residents in areas with medium-low incidence of gastric cancer in Fujian,and the possibility of using serum markers screening high-risk groups. [Methods] The person being investigated randomly from Tongan district and Fuan city received the interview questionnaires and were detected serum PG Ⅰ ,PG Ⅱ ,G-17,Hp detection. [Results] PG Ⅰ level showed significant differences in gender, age, region distribution. PG Ⅱ , PG Ⅰ / PG Ⅱ level also showed significant difference in region distribution. PG Ⅰ ,PG Ⅱ,PG Ⅰ/PG Ⅱ, G-17 level were significantly different between positive Hp infection and negative Hp infection(all P〈0.05). Logistic regression analysis showed no factor caused abnormal levels of PG I ,PG Ⅰ/PG Ⅱ ,but Hp infection(OR=2.656) and middle aged (OR= 2.114) were high risks for G-17 abnormal levels. [Conclusionl PG Ⅰ ,PG Ⅱ ,G-17 have a broad prospect of screening for high-risk population with gastric cancer.
出处 《中国肿瘤》 CAS 2014年第3期209-213,共5页 China Cancer
基金 国家卫生计生委共建科学基金--福建省卫生教育联合攻关计划项目(WKJ-FJ-18)
关键词 胃癌 胃蛋白酶原Ⅱ 胃蛋白酶原Ⅱ 胃泌素-17 幽门螺杆菌 gastric cancer pepsinogen Ⅰ pepsinogen Ⅱ gastrin- 17 helicohacter pylori
  • 相关文献

参考文献13

  • 1Kang JM,Kim N,Yoo JY,et al. The role of serum pepsinogen and gastrin test for the detection of gastric cancer in Korea [J].Helicobacter, 2008,13(2) : 146-156.
  • 2Mukoubayashi C,Yanaoka K,Ohala H,et al. Serum pepsinogen and gastric cancer screening[J]. Intern Med,2007, 46 (6) : 261-266.
  • 3Vails K, Sipponen P,Laxen F, et al. Implications of serum pepsinogen I in early endoscopic diagnosis of gastric cancer and dysplasia [J]. Scand J Gastroenterol,2000,35 (9) : 950-956.
  • 4Germana B, Di Mario F,Cavallaro LG,et al. Clinical use- fulness of serum pepsinogens I and II,gastrin-17 and anti-Helicobacter pylori antibodies in the management of dyspeptic patients in primary care[J].Dig Liver Dis,2005, 37(7):501-508.
  • 5Shiotani A,Iishi H,Uedo N,et al. Histologic and serum risk markers for noncardia early gastric cancer[J]. Int J Cancer, 2005,115(3) :463-469.
  • 6Ohkusa T,Miwa H,Nomura T,et al. Improvement in serum pepsinogens and gastrin in long-term monitoring af- ter eradication of Helicobacter pylori:comparison with H. pylori-negative patients[J]. Aliment Pharmaclo Ther ,2004, 20 (Suppl 1) : 25-32.
  • 7Kazuo A ,Junichi M. Statistical analysis of serum pepsino- gen Ⅰ (PG Ⅰ ) and Ⅱ (PG Ⅱ) levels, PG Ⅰ/PG Ⅱ ratios and serum gastrin levels in a general population[J]. Envi- ron Health Prey Med, 1996,1(3): 136-143.
  • 8张祥宏,赵文元,孙旭明,卜玉华,严霞,王俊灵,王会艳,张振国,米建民,谢同欣,三角顺一,青木一雄,王凤荣.胃癌高发区农村居民血清胃蛋白酶原和胃泌素分析[J].中国公共卫生,2002,18(3):287-288. 被引量:19
  • 9Broutet N,Plebani M,Sakarovitch C,et al. Pepsinogen A, pepsinogen C,and gastrin as markers of atrophic chronic gastritis in European dyspeptics [J]. Br J Cancer,2003,88 (8): 1239-1247.
  • 10孙丽萍,宫月华,王兰,董明,袁媛.辽宁庄河地区居民血清胃蛋白酶原含量检测分析[J].中华消化杂志,2006,26(10):649-652. 被引量:37

二级参考文献23

共引文献89

同被引文献81

引证文献8

二级引证文献89

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部